Furthermore, TNBC has been proven to be the most immunogenic tumor type among other breast cancer subtypes that were described by immunochemistry (IHC) staining according to the expression of estrogen or progesterone receptors or HER2 [6]. This evidence concerns the gene ERBB2 and breast carcinoma.